These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 18006315

  • 21. Inhibition of cathepsin D by tripeptides containing statine analogs.
    Bessodes M, Antonakis K, Herscovici J, Garcia M, Rochefort H, Capony F, Lelièvre Y, Scherman D.
    Biochem Pharmacol; 1999 Jul 15; 58(2):329-33. PubMed ID: 10423175
    [Abstract] [Full Text] [Related]

  • 22. Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
    Hidaka K, Kimura T, Tsuchiya Y, Kamiya M, Ruben AJ, Freire E, Hayashi Y, Kiso Y.
    Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3048-52. PubMed ID: 17400453
    [Abstract] [Full Text] [Related]

  • 23. Beta-amino acid substitutions and structure-based CoMFA modeling of hepatitis C virus NS3 protease inhibitors.
    Nurbo J, Peterson SD, Dahl G, Helena Danielson U, Karlén A, Sandström A.
    Bioorg Med Chem; 2008 May 15; 16(10):5590-605. PubMed ID: 18434166
    [Abstract] [Full Text] [Related]

  • 24. The protease of human T-cell leukemia virus type-1 is a potential therapeutic target.
    Tözsér J, Weber IT.
    Curr Pharm Des; 2007 May 15; 13(12):1285-94. PubMed ID: 17504236
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluations of substrate specificity and inhibition at PR/p3 cleavage site of HTLV-1 protease.
    Naka H, Teruya K, Bang JK, Aimoto S, Tatsumi T, Konno H, Nosaka K, Akaji K.
    Bioorg Med Chem Lett; 2006 Jul 15; 16(14):3761-4. PubMed ID: 16682197
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Characterizing the protonation states of the catalytic residues in apo and substrate-bound human T-cell leukemia virus type 1 protease.
    Ma S, Vogt KA, Petrillo N, Ruhoff AJ.
    Comput Biol Chem; 2015 Jun 15; 56():61-70. PubMed ID: 25889320
    [Abstract] [Full Text] [Related]

  • 31. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
    Nakatani S, Hidaka K, Ami E, Nakahara K, Sato A, Nguyen JT, Hamada Y, Hori Y, Ohnishi N, Nagai A, Kimura T, Hayashi Y, Kiso Y.
    J Med Chem; 2008 May 22; 51(10):2992-3004. PubMed ID: 18426195
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Early sequential development of infective dermatitis, human T cell lymphotropic virus type 1-associated myelopathy, and adult T cell leukemia/lymphoma.
    Farre L, de Oliveira Mde F, Primo J, Vandamme AM, Van Weyenbergh J, Bittencourt AL.
    Clin Infect Dis; 2008 Feb 01; 46(3):440-2. PubMed ID: 18173359
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. HIV-1 protease cleavage site prediction based on amino acid property.
    Niu B, Lu L, Liu L, Gu TH, Feng KY, Lu WC, Cai YD.
    J Comput Chem; 2009 Jan 15; 30(1):33-9. PubMed ID: 18496789
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A novel series of highly selective inhibitors of MMP-3.
    Whitlock GA, Dack KN, Dickinson RP, Lewis ML.
    Bioorg Med Chem Lett; 2007 Dec 15; 17(24):6750-3. PubMed ID: 18029177
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.